2-chloro-n(6)cyclopentyladenosine has been researched along with Absence Status in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acon-Chen, C; Loughery, TN; Shih, TM; Whitten, KA | 1 |
| Cock, HR; Hamil, NE; Walker, MC | 1 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Absence Status
| Article | Year |
|---|---|
Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Brain; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Injections, Intramuscular; Male; Neuroprotective Agents; Norbornanes; Rats, Sprague-Dawley; Sarin; Soman; Status Epilepticus; Time Factors | 2021 |
Acute down-regulation of adenosine A(1) receptor activity in status epilepticus.
Topics: Adenosine; Animals; Disease Models, Animal; Down-Regulation; Electric Stimulation; Electroencephalography; Hippocampus; Male; Rats; Rats, Wistar; Receptor, Adenosine A1; Status Epilepticus | 2012 |